Delivery Order SPE2DB24D1205-SPE2DB24FCTCW

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999 through November 2026, covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs,...
This is a $1,046.71 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, with a completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,296.32 delivery order is for the supply of Epinephrine 0.3 mg auto-injectors, a critical emergency medication. Amerisourcebergen holds a $999,999,999 IDC with DLA Troop Support Medical to provide a comprehensive range of medical commodities in support of military treatment programs...
This is a Delivery Order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,141.05, is for the supply of 4563079681 - EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical devices. The IDC held by AmerisourceBergen with DLA Troop Support Medical is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,223.59 firm fixed-price contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, with a completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The $6,360.77 firm fixed-price contract has a completion date of February 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order under a larger indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $4,582.18 delivery order is for the supply of 4565425909 EPINEPHRINE 0.15 MG AUTO-INJCT 2S, a critical medical product used to treat severe allergic reactions. This delivery order has a firm fixed price and is expected to be completed by August 13, 2024. Amerisourcebergen, a major...
This is a $3,369.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies, with a completion date of January 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order award under an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,329.88 firm fixed-price delivery order is for the supply of epinephrine 0.3 mg auto-injectors. The award has an ultimate completion date of August 2, 2024. Amerisourcebergen holds a significant IDC with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, with a ceiling value of $1,155.04 and a completion date of February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCTCW
    Delivery Order

This is a Delivery Order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,334.95, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to support military healthcare programs.

AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic areas to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This Delivery Order is part of that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:56 AM